期刊文献+

儿童皮肌炎20例临床分析 被引量:1

原文传递
导出
摘要 目的探讨儿童皮肌炎(JDM)的临床特点,为临床诊治提供依据。方法回顾性分析本院诊治的20例JDM患儿的临床表现、实验室检查、治疗及转归。结果20例患儿中男7例,女13例,男女比例为1:1.9,发病年龄3—14(10.14-4.0)岁。20例患儿中首发症状以皮肤损害为主者,占45%(9/20)。35%(7/20)的患儿发病前4周有呼吸道或胃肠道的感染。所有患儿均有皮肤损害,18例有不同程度的肌肉症状伴肌酶升高,2例为临床无肌病性皮肌炎(C-ADM)。46.2%(6/13)的患儿肺部高分辨率CT(HRCT)显示有肺间质性改变。84.6%(11/13)的患儿肌肉磁共振(MRI)显示有活动性的肌炎或筋膜炎。所有患儿均采用糖皮质激素治疗,其中17例联合应用免疫抑制剂治疗。10例重症及其难治性的JDM患儿加用了霉酚酸酯治疗,其症状改善明显。90%(18/20)的患儿病情稳定后出院,远期并发症少。结论JDM是一种少见的自身免疫性疾病,早期规范化给予糖皮质激素治疗,联合免疫抑制剂可以减少糖皮质激素的用量,可降低并发症,改善其预后。
出处 《中国医师杂志》 CAS 2011年第9期1222-1224,共3页 Journal of Chinese Physician
  • 相关文献

参考文献11

  • 1Ravelli A,Trail L,Ferrari C,et al.Long-term outcome and prognostic facors of juvenile dermatomyositis:a multinational,multicenter study of 490 patients.Arthritis Care Res,2010,62(1):63-72.
  • 2Kim S,El-Hallak M,Dedeoglu F,et al.Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.Arthritis Rheum,2009,60 (6):1825-1830.
  • 3Bohan A,Peter JR.Polymyositis and dermatomyositis (first of two parts).N Engl J Med,1975,292(7):344-347.
  • 4Bohan A,Peter JR.Polymyositis and dermatomyositis (second of two parts).N Engl J Med,1975,292(8):403-407.
  • 5Brown VE,Pilkington CA,Feldman BM,et al.An international consensus survey of the diagnostic criteria for juvenile dermatomyositis(JDM).Rheumatology,2006,45(8):990-993.
  • 6Wedderbum LR,Rider LG.Juvenile dermatomyositis:new developments in pathogenesis,assessment and treatment.Best Pract Res Clin Rheumatol,2009,23 (5):665-78.
  • 7Pachman LM,Lipton R,Ramsey-Goldman R,et al.History of infection before the onset of juvenile dermatomyositis:results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.Arthritis Rheum,2005,53(2):166-172.
  • 8陈益和,唐福林.临床无肌病性皮肌炎[J].中华临床免疫和变态反应杂志,2007,1(1):90-95. 被引量:2
  • 9McCann LJ,Juggins AD,Maillard SM,et al.The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) clinical characteristics of children recruited within the first 5 years.Rheumatology,2006,45 (10):1255-1260.
  • 10Rouster-Stevens KA,Morgan GA,Wang D,et al.Mycophenolate mofetil:a possible therapeutic agent for children with juvenile dermatomyositis.Arthritis Care Res,2010,62(10):1446-1451.

二级参考文献15

  • 1谢娟,杨美平,黄艳春.无肌病性皮肌炎并乙型肝炎一例[J].实用临床医学(江西),2004,5(4):63-63. 被引量:2
  • 2张清安,李中学,向兰兰,黄娟.皮肌炎与多发性肌炎73例临床分析[J].中国实用内科杂志,2005,25(4):354-355. 被引量:4
  • 3忻霞菲,张长宋.无肌病性皮肌炎伴肿瘤3例[J].中国麻风皮肤病杂志,2005,21(4):325-325. 被引量:3
  • 4Jane H. Park MD,Nancy J. Olsen MD.Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies[J].Current Rheumatology Reports.2001(4)
  • 5S. K. Chow,S. S. Yeap.Amyopathic Dermatomyositis and Pulmonary Fibrosis[J].Clinical Rheumatology.2000(6)
  • 6Pearson CM.Polymyoaitis and dermatomyositia[].Arthritis(and allied conditions).1979
  • 7Euwer RL,Sontheimer RD.Amyopathic dermatomyositis(dermatomyositis sinémyositis):presentation of six new cases and review of the literature[].Journal of the American Academy of Dermatology.1991
  • 8Sontheimer RD.Would a new name hasten the acceptance of amyopathic dermatomyositia(dermatomyositis sinémyoaitis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness[].Journal of the American Academy of Dermatology.2002
  • 9Rocamora V,Puig L,Alomar A.Dermatomyositis-like eruption following hydroxyurea therapy[].Journal of the European Academy of Dermatology and Venereology.2000
  • 10Thune P.The coexistence of amyopathie dennatomyositis and fibromyalgia[].Acta Dermato Venereologica.2000

共引文献1

同被引文献13

  • 1陈学良,李湘新,李颢,等.以副肿瘤皮肌炎为首发症状的骨髓异常增生综合征1例[J].中华麻风皮肤病杂志,2007,23(121:1098-1099.
  • 2Marie I, Guillevin L, Menard JF, et al. Hematological ma- lignancy associated with polymyositis and dermatomyositis [J]. Autoimmun Rev,2012,11(9): 615-620.
  • 3Huang YL, Chen Y J, Lin MW, et al. Malignancies as- sociated with dermatomyosifis and polymyositis in Taiwan:a nationwide population based. Study [J]. Br J Dermatol, 2009, 161(4): 854-860.
  • 4Bohan A, Peter JB. Polymyositis and dermatomyositis [J]. N Engl J Med, 1975,292(8): 403-407.
  • 5Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study [J]. Br J Dermatol, 2001, 144(4): 825-831.
  • 6Marie I, Mouthon L. Therapy of polymyositis and dermato- myositis [J]. Autoimmun Rev, 2011,11(1): 6-13.
  • 7Dalakas MC. Pathogenesis and therapies of immune-mediated myopathies [J]. Autoimmun Rev, 2012,11(3): 203-206.
  • 8Maeda Y, Arakawa K, Araki E, et al. Polymyositis and cu- taneous vasculitis in a patient with myelodysplastic syndrome [J]. Rinsho Shinkeigaku, 1999, 39(6): 639-642.
  • 9Tsuji G, Maekawa S, Saigo K, et al. Dermatomyositis and myelodysplastic syndrome with myelofibrosis responding to methotrexate therapy [J]. Am J Hematol, 2003, 74(3): 175-178.
  • 10宋英杰,樊涛,吴云飞,金峰,王超奇.以皮肤病为首发表现的恶性肿瘤临床分析[J].中华肿瘤防治杂志,2010,17(11):866-868. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部